Latest filing published 03 Jun 2026 for Amphastar Pharmaceuticals, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Michael A. Zasloff in Amphastar Pharmaceuticals, Inc., where the filings describe the role as board member. Between 13 May 2021 and 1 June 2026, the trades on record add up to 12 filings.
No open-market purchase appears, only 3 sales worth €1.4M. The rest of the record consists of 6 share grants and 3 option exercises.
Most recently, on 3 June 2026, the filings show a share grant in Amphastar Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations